A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis

Abroad (travel likely)RecruitingPHASE1

Conditions

Atopic Dermatitis (AD)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

ZaiLab Site 18001, Auckland, Auckland, New Zealand

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)

Atopic Dermatitis

Abroad (travel likely)RecruitingPHASE1

Irvine, United States · New York, United States

A Phase I Study of SSGJ-716 in Healthy Adults and Participants With Moderate-to-Severe Atopic Dermatitis

Abroad (travel likely)RecruitingPHASE1

Shanghai, China

Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234

Atopic Dermatitis (AD) · Eczema

Abroad (travel likely)RecruitingPHASE1

Fair Lawn, United States

Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis

Atopic Dermatitis (AD) · Psoriasis (PsO)

Abroad (travel likely)RecruitingPHASE1

Fargo, United States · Dallas, United States